Ethyl 7-[3-[(E)-1-methylsulfanyloct-2-enyl]-2-oxooxolan-3-yl]hept-5-enoate
C22H36O4S — CID 70601961
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethyl 7-[3-[(E)-1-methylsulfanyloct-2-enyl]-2-oxooxolan-3-yl]hept-5-enoate
Ethyl 7-[3-[(E)-1-methylsulfanyloct-2-enyl]-2-oxooxolan-3-yl]hept-5-enoate (PubChem CID 70601961) has the molecular formula C22H36O4S and a molecular weight of 396.59 g/mol. Its IUPAC name is ethyl 7-[3-[(E)-1-methylsulfanyloct-2-enyl]-2-oxooxolan-3-yl]hept-5-enoate.
Molecular Properties
| Compound Name | Ethyl 7-[3-[(E)-1-methylsulfanyloct-2-enyl]-2-oxooxolan-3-yl]hept-5-enoate |
|---|---|
| PubChem CID | 70601961 |
| Molecular Formula | C22H36O4S |
| Molecular Weight | 396.59 g/mol |
| Exact Mass | 396.23 |
| IUPAC Name | ethyl 7-[3-[(E)-1-methylsulfanyloct-2-enyl]-2-oxooxolan-3-yl]hept-5-enoate |
| SMILES | CCCCC/C=C/C(SC)C1(CC=CCCCC(=O)OCC)CCOC1=O |
| InChI | InChI=1S/C22H36O4S/c1-4-6-7-8-11-14-19(27-3)22(17-18-26-21(22)24)16-13-10-9-12-15-20(23)25-5-2/h10-11,13-14,19H,4-9,12,15-18H2,1-3H3/b13-10?,14-11+ |
| InChIKey | ZZHUMGSNTWZLRF-LMJSHCNKSA-N |
| XLogP | 5.47 |
| TPSA | 52.60 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 14 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 396.59 |
| LogP ≤ 5 | 5.47 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 70601961 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.